The Fifth Circuit today gave the FTC (and U.S. consumers) a huge win today in finding that Endo and Impax entered into a pay-for-delay settlement that delayed the entry of opioid Opana ER.

The opinion reached the result suggested by Prof. Michael Carrier in his brief on behalf of 82 professors.

Link to opinion…

FTC v. Impax ruling